CRES-102

N/A

Report date: 2025/01/26 18:07:50
NME

Base Information

Drug NameCRES-102
Drug Alias NameCRES-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCresence AS
China Registration ClassN/A

Develop Information

Active CompaniesCresence AS
Inactive CompaniesN/A
Active IndicationsNerve DegenerationMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A